Computational screening of natural products to identify potential inhibitors for human neuropilin-1 (NRP1) receptor to abrogate the binding of SARS-CoV-2 and host cell-Reference-Cited by-同舟云学术

Computational screening of natural products to identify potential inhibitors for human neuropilin-1 (NRP1) receptor to abrogate the binding of SARS-CoV-2 and host cell

Published:2022-11-28 Issue: Volume: Page:1-10
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Karkashan Alaa¹,Attar Roba¹^ORCID

Affiliation:

1. Department of Biology, College of Sciences, University of Jeddah, Jeddah, Saudi Arabia

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2022.2150685

Reference45 articles.

1. Molecular dynamic study of SARS-CoV-2 with various S protein mutations and their effect on thermodynamic properties

2. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency

3. In-silico studies of glutathione peroxidase4 activators as candidate for multiple sclerosis management

4. Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro

5. Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Product Cordycepin (CD) Inhibition for NRP1/CD304 Expression and Possibly SARS-CoV-2 Susceptibility Prevention on Cancers;Microorganisms;2023-12-10

2. Comprehensive analysis and immunohistochemistry localization of NRP1 expression in pancancer and normal individual tissues in relation to SARS‑CoV‑2 susceptibility;Experimental and Therapeutic Medicine;2023-12-05

3. Extracellular Vesicle-Based SARS-CoV-2 Vaccine;Vaccines;2023-02-24